A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositisAdam Schiffenbauer, Mark F. Gourley, Paul H. Plötz et al.|Seminars in Arthritis and Rheumatism|2017Cited by 70
The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositisAdam Schiffenbauer, Frederick W. Miller, Willy A. Flegel et al.|Seminars in Arthritis and Rheumatism|2018Cited by 44
Rheumatology capacity building: implementing a rheumatology curriculum for Liberian health-care providers in 2016Laura B. Lewandowski, James D. Katz, Mosaka P. Fallah et al.|Clinical Rheumatology|2020Cited by 8